Company Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 16:35:14 06/03/2026 GMT			5-day change	1st Jan Change
121.80 ^GBX	-1.77%		-8.49%	-5.14%

03-03	Oxford Nanopore chair Tatton-Brown buys GBP100,000 in shares	AN
03-02	Oxford Nanopore Technologies plc Provides Earnings Guidance for the Year 2026	CI

Business description: Oxford Nanopore Technologies plc

Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Companyâ€™s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.

Number of employees: 1,335

Sales by Activity: Oxford Nanopore Technologies plc

Fiscal Period: December	2020 (GBP)	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)
Life Science Research Tools (LSRT)	65.53M	127M	147M	170M	183M
COVID Testing	48.33M	6.7M	51.79M	-	-

See all business segments

Geographical breakdown of sales: Oxford Nanopore Technologies plc

Fiscal Period: December	2020 (GBP)	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)
Rest of World	13.78M	-	-	-	75.7M
USA	16.41M	-	-	-	56.16M
United Kingdom	52.88M	-	-	-	21.13M
China	7.72M	10.98M	19.29M	-	16.04M
Germany	-	-	-	-	11.01M
United Arab Emirates	-	31.72M	15.38M	-	3.15M
Europe, The Middle East, Africa, and India	-	-	-	74.04M	-
APAC	-	-	-	34.09M	-
Emerging Markets	-	6.36M	6.22M	-	-
Asia Pacific and Japan	-	11.13M	14.29M	-	-
Europe and United Kingdom	-	40.1M	95.12M	-	-
Americas	-	33.37M	48.3M	61.54M	-
Europe Excluding UK	18.91M	-	-	-	-
Japan	4.16M	-	-	-	-

See all geographic segments

Executive Committee: Oxford Nanopore Technologies plc

Manager	Title	Age	Since
Gordon Sanghera CEO	Chief Executive Officer	-	22/05/2005
Nicholas Keher DFI	Director of Finance/CFO	44	21/01/2024
Lakmal Jayasinghe CTO	Chief Tech/Sci/R&D Officer	-	10/11/2024
Timothy Cowper DFI	Director of Finance/CFO	-	31/12/2011
Philip Watkins PRN	Corporate Officer/Principal	-	31/12/2019

See OXFORD NANOPORE TECHNOLOGIES PLC governance

Composition of the Board of Directors: Oxford Nanopore Technologies plc

Director	Title	Age	Since
Gordon Sanghera BRD	Director/Board Member	-	31/12/2004
John O'Higgins BRD	Director/Board Member	61	31/08/2019
Adrian Hennah BRD	Director/Board Member	68	23/06/2021
Duncan Tatton-Brown CHM	Chairman	61	31/07/2022
Kate Priestman BRD	Director/Board Member	53	12/07/2023
Sarah Fortune BRD	Director/Board Member	-	18/12/2023
Heather Preston BRD	Director/Board Member	60	18/12/2023
Nicholas Keher BRD	Director/Board Member	44	21/01/2024
Daniel Mahony BRD	Director/Board Member	-	30/09/2024

Composition of the Board of Directors

Shareholders: Oxford Nanopore Technologies plc

Name	Equities	%	Valuation
Eit Oxford Holdings LLC 16.95 %	163,748,959	16.95 %	348 M p
IP GROUP PLC 9.823 %	94,895,725	9.823 %	202 M p
TENCENT HOLDINGS LIMITED 6.534 %	63,117,700	6.534 %	134 M p
BIOMÉRIEUX 6.114 %	59,062,832	6.114 %	126 M p
Novo Holdings A/S (Investment Company) 5.155 %	49,800,000	5.155 %	106 M p

List of OXFORD NANOPORE TECHNOLOGIES PLC shareholders

Company details: Oxford Nanopore Technologies plc

Oxford Nanopore Technologies Plc

Gosling Building

OX4 4DQ, Oxford

+44 84 5034 7900

http://nanoporetech.com

address Oxford Nanopore Technologies plc(ONT)

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
OXFORD NANOPORE TECHNOLOGIES PLC	-1.77%	-8.49%	+31.11%	-42.68%	1.58B
THERMO FISHER SCIENTIFIC, INC.	-3.25%	-3.67%	-4.87%	-10.12%	186B
INTUITIVE SURGICAL, INC.	-1.32%	-2.65%	-8.99%	+108.71%	174B
DANAHER CORPORATION	-3.22%	-7.19%	-8.99%	-21.75%	138B
BOSTON SCIENTIFIC CORPORATION	-2.25%	-7.16%	-29.22%	+49.46%	106B
SIEMENS HEALTHINEERS AG	-0.22%	-4.11%	-23.32%	-20.20%	52.29B
EDWARDS LIFESCIENCES CORPORATION	-2.68%	-5.59%	+13.70%	+3.60%	47.42B
RESMED, INC.	-0.96%	-1.32%	+12.37%	+15.38%	36.84B
GE HEALTHCARE TECHNOLOGIES INC.	-3.68%	-11.87%	-13.04%	-3.14%	33.85B
AGILENT TECHNOLOGIES, INC.	-2.57%	-5.20%	-9.07%	-19.66%	32.52B
Average	-2.19%	-4.68%	-4.03%	+5.96%	80.92B
Weighted average by Cap.	-2.35%	-4.00%	-9.40%	+22.41%